160 related articles for article (PubMed ID: 37540268)
1. Objective Definition and Optimized Strategy for "Biologically Borderline Resectable" Colorectal Liver Metastases.
Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K; Hashimoto T; Makuuchi M
World J Surg; 2023 Nov; 47(11):2834-2845. PubMed ID: 37540268
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis.
Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M
World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
[TBL] [Abstract][Full Text] [Related]
4. Borderline resectable for colorectal liver metastases: Present status and future perspective.
Kitano Y; Hayashi H; Matsumoto T; Kinoshita S; Sato H; Shiraishi Y; Nakao Y; Kaida T; Imai K; Yamashita YI; Baba H
World J Gastrointest Surg; 2021 Aug; 13(8):756-763. PubMed ID: 34512899
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.
Ninomiya M; Emi Y; Motomura T; Tomino T; Iguchi T; Kayashima H; Harada N; Uchiyama H; Nishizaki T; Higashi H; Kuwano H
Int J Clin Oncol; 2021 Dec; 26(12):2255-2264. PubMed ID: 34519930
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.
Chen FL; Wang YY; Liu W; Xing BC
Front Oncol; 2022; 12():973418. PubMed ID: 36132151
[TBL] [Abstract][Full Text] [Related]
7. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
8. Oncological outcomes of neoadjuvant chemotherapy in patients with resectable synchronous colorectal liver metastasis: A result from a propensity score matching study.
Jiang YJ; Zhou SC; Chen JH; Liang JW
Front Oncol; 2022; 12():951540. PubMed ID: 36330479
[TBL] [Abstract][Full Text] [Related]
9. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?
Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K
Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329
[TBL] [Abstract][Full Text] [Related]
10. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
Lee JM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
J Surg Oncol; 2023 Sep; 128(4):549-559. PubMed ID: 37288777
[TBL] [Abstract][Full Text] [Related]
13. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
[TBL] [Abstract][Full Text] [Related]
14. Combined ablation and resection (CARe) for resectable colorectal cancer liver Metastases-A propensity score matching study.
Liu M; Wang Y; Wang K; Bao Q; Wang H; Jin K; Liu W; Yan X; Xing B
Eur J Surg Oncol; 2023 Sep; 49(9):106931. PubMed ID: 37183048
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study.
Kitano Y; Ono Y; Kobayashi K; Oba A; Sato T; Ito H; Inoue Y; Shinozaki E; Yamaguchi K; Saiura A; Baba H; Takahashi Y
HPB (Oxford); 2024 Feb; 26(2):282-290. PubMed ID: 37985325
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis.
Zhang Y; Ge L; Weng J; Tuo WY; Liu B; Ma SX; Yang KH; Cai H
World J Clin Cases; 2021 Aug; 9(22):6357-6379. PubMed ID: 34435001
[TBL] [Abstract][Full Text] [Related]
17. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
Front Oncol; 2021; 11():758552. PubMed ID: 34745996
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study.
Behrenbruch C; Prabhakaran S; Udayasiri D; Hollande F; Michael M; Hayes I; Heriot A; Knowles B; Thomson B
ANZ J Surg; 2021 Jun; 91(6):1196-1202. PubMed ID: 33543551
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
Chen Y; Huang Y; Xu L; Wu J; Han F; Jiang H; Zheng P; Xu D; Zhang Y
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
